Company Filing History:
2 out of 2 
1 out of 1 
1 out of 1 
Years Active: 2018-2025
Title: Dariusz Pawlak: Innovator in Pharmaceutical Chemistry
Introduction
Dariusz Pawlak is a notable inventor based in Bialystok, Poland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with potential anticancer properties. With a total of 2 patents, his work showcases the intersection of innovation and medical science.
Latest Patents
Dariusz Pawlak's latest patents include the development of L-proline sulfonamide derivatives comprising a pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine system. This invention relates to novel sulfonamide derivatives that exhibit cytostatic activity against gastric and colorectal cancer cell lines. The compounds may serve as new medicaments with anticancer action. Additionally, he has patented the use of a block polymer comprising poly(3-(methacryloylamino)propyltrimethylammonium chloride) for the neutralization of heparin in blood and other body fluids.
Career Highlights
Dariusz has worked at prominent institutions such as the Medical University of Bialystok and the University of Natural Sciences and Humanities in Siedlce. His academic and research endeavors have significantly contributed to advancements in pharmaceutical applications.
Collaborations
Throughout his career, Dariusz has collaborated with notable colleagues, including Mariusz Mojzych and Katarzyna Kotwica-Mojzych. These partnerships have fostered a collaborative environment that enhances research outcomes.
Conclusion
Dariusz Pawlak stands out as an innovative inventor in the realm of pharmaceutical chemistry. His contributions through patents and collaborations reflect his commitment to advancing medical science and improving therapeutic options.